Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Clinical trial NCT02455297 · TERMINATED
Trial details
- NCT number
- NCT02455297
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-24
- Primary completion
- 2016-04-08
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.